ArticleAmerican journal of respiratory cell and molecular biology2025
A Human Single-Nuclei Atlas Reveals Novel Cell States during the Pseudoglandular-to-Canalicular Transition.
Article in American journal of respiratory cell and molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Endothelial Continuum and Capillary Specialization in Pulmonary Vascular Development.Arteriosclerosis, thrombosis, and vascular biology · 2026Review
- Gene-ius at Work: Decoding Cell States through Expression.American journal of respiratory cell and molecular biology · 2025Article
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
Abstract
Most of our knowledge of human lung development is derived from morphologic studies and extrapolations of the underlying molecular mechanisms from animal models. Here we describe developmental changes in human fetal lungs during the pseudoglandular and early canalicular period, detailing this critical but previously poorly described transition period. We report the cellular composition and cell-to-cell communication in a single-nuclei dataset from nine human fetal lungs between 14 and 19 weeks of gestation. We identified 9 main populations and 19 subpopulations, including the rare pulmonary neuroendocrine cells. For each population, marker genes were reported, and selected markers were validated. Enrichment analysis were performed to explore the potential molecular mechanisms and pathways within individual populations according to gestational age. Finally, cell-to-cell communication was studied using ligand-receptor analysis among the different cell types. General developmental pathways, as well as pathways involved in vasculogenesis, neurogenesis, and immune regulation, were identified. This study provides an important background to generate research hypotheses in projects studying normal or impaired lung development and help to validate surrogate models (e.g., lung organoids) to study human lung development.
Indexed as
Identifiers
40198804What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.